Abdul Abdirahman
Principal
F-Prime
Principal investing in early-stage B2B software, fintech, and vertical SaaS.
Professional summary
Martin Taylor is a Principal at F-Prime focused on biotechnology investment and company creation across oncology, cardiovascular, renal and metabolic diseases, and rare disease. He joined F-Prime's London office in 2019 and has worked on biotechnology company creation efforts and investments in Europe, including ARTBIO, CHARM Therapeutics, and Tenpoint Therapeutics. Before F-Prime, he was a Wellcome Trust Sir Henry Wellcome Postdoctoral Fellow at the MRC Laboratory of Molecular Biology.
Selected portfolio companies the partner has backed
Career, education, and skills
12 more profiles